Elixir
Recent News
- Elixir Pharmaceuticals to Present at the UBS Global Life Sciences Conference , Release, September 18, 2008
- Elixir Pharmaceuticals Announces Exclusive Sirtuin Intellectual Property License Agreement with Boston University , Release, July 1, 2008
- Elixir Pharmaceuticals Announces New Data at the 2008 American Diabetes Association Annual Meeting, Business Wire, June 9, 2008
- Elixir Pharmaceuticals Researchers Publish New Data Validating Ghrelin as a Key Metabolic Regulator, Business Wire, May 28, 2008
- Elixir Pharmaceuticals Announces Issuance of SIRT Patent Covering Development of New Therapies Based on Breakthrough Science, Business Wire, April 28, 2008
- Elixir Establishes National Diabetes Advisory Board, Business Wire, April 9, 2008
- Elixir Completes Enrollment in Pivotal Phase III Clinical Trial for New Diabetes Drug, Business Wire, March 25, 2008
- Elixir Names Presents New Data on Ghrelin Inhibition at Keystone Meeting, Release, February 22, 2008
- Elixir Taps Chief Medical Officer, Boston Business Journal, October 25, 2007
- Elixir Names Paul M. Martha, MD as Chief Medical Officer, Release, October 25, 2007
News Archive
- Elixir Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering, Genetic Engineering & Biotechnology News, September 24, 2007